Hansa Biopharma Ab
Clinical trials sponsored by Hansa Biopharma Ab, explained in plain language.
-
New drug could unlock kidney transplants for sensitized kids
Disease control Recruiting nowThis trial tests a drug called imlifidase in highly sensitized children aged 1-17 who need a kidney transplant. The drug aims to quickly clear antibodies that would normally cause rejection, turning a positive crossmatch negative and allowing the transplant to happen. Researchers…
Phase: PHASE2 • Sponsor: Hansa Biopharma AB • Aim: Disease control
Last updated Jun 22, 2026 11:59 UTC
-
5-year follow-up checks if imlifidase helps kidney transplants last longer
Disease control Recruiting nowThis study follows 150 people who received imlifidase before a kidney transplant to see how long their new kidney works. Researchers will check for graft failure (return to dialysis, re-transplant, or kidney removal) over 5 years. A separate group of similar patients not receivin…
Phase: PHASE3 • Sponsor: Hansa Biopharma AB • Aim: Disease control
Last updated Jun 16, 2026 12:53 UTC